Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rajagopalan

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
British Journal of Cancer|November 13, 2008
Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumoursD Strumberg, B Schultheis, I A Adamietz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 25, 2003
Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable renal allograft recipientsMark D Pescovitz, Antonio Guasch, Robert Gaston, et al.
Journal of Medicinal Chemistry|September 1, 1990
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 2. The "A" groupW A Gregory, D R Brittelli, C L Wang, et al.
Transplantation|October 24, 2002
Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulationAllan Roza, Stephen Tomlanovich, Robert Merion, et al.
Neuroscience|May 20, 2014
Physical activity, inflammation, and volume of the aging brainM N Braskie, C P Boyle, P Rajagopalan, et al.
Psychiatry Research|October 7, 1996
Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation methodC E Byrum, J R MacFall, H C Charles, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
British Journal of Cancer|November 13, 2008
Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumoursD Strumberg, B Schultheis, I A Adamietz, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 25, 2003
Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable renal allograft recipientsMark D Pescovitz, Antonio Guasch, Robert Gaston, et al.
Journal of Medicinal Chemistry|September 1, 1990
Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxooxazolidines. 2. The "A" groupW A Gregory, D R Brittelli, C L Wang, et al.
Transplantation|October 24, 2002
Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulationAllan Roza, Stephen Tomlanovich, Robert Merion, et al.
Neuroscience|May 20, 2014
Physical activity, inflammation, and volume of the aging brainM N Braskie, C P Boyle, P Rajagopalan, et al.
Psychiatry Research|October 7, 1996
Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation methodC E Byrum, J R MacFall, H C Charles, et al.
Pageof 6